Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells (Q42527191)

1 November 2017

Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells (English)

1 reference

1 November 2017

0 references

1 reference

1

1 reference

1 November 2017

4

Joseph Loscalzo

1 reference

1 November 2017

5

Louis J Ignarro

1 reference

1 November 2017

3

Filomena de Nigris

1 reference

1 November 2017

2

Lilach O Lerman

1 reference

PubMed ID

12392844

1 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of the American College of Cardiology

1 November 2017

1 reference

1 November 2017

40

1 reference

1 November 2017

8

1 reference

1 November 2017

1515-1522

1 reference

Low density lipoprotein oxidation and its pathobiological significance

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Vascular cell apoptosis in remodeling, restenosis, and plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells∗

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Evidence for Oxidative Activation of c-Myc–Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Multiple role of reactive oxygen species in the arterial wall.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

c-myc activation in early coronary lesions in experimental hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Nitric oxide as a signaling molecule in the vascular system: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Nitric oxide and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Non-enzymatic glycosylation and the chronic complications of diabetes: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Glycation, oxidation, and lipoxidation in the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

A Simple and Rapid Purification Procedure Minimizes Spontaneous Oxidative Modifications of Low Density Lipoprotein and Lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

AU-rich elements: characterization and importance in mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902306-9

7 January 2021

Protein measurement with the Folin phenol reagent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0735-1097(02)02306-9

Identifiers

DOI

10.1016/S0735-1097(02)02306-9

1 reference

1 November 2017

1 reference

PubMed ID

12392844